The effect of a C-terminal peptide of surfactant protein B (SP-B) on oriented lipid bilayers, characterized by solid-state 2H- and 31P-NMR

Biophysical Journal

Volumn 96, Issue 9, 2009, Pages 3762-3771

  Yang, Tran Chin ^a   McDonald, Mark ^a   Morrow, Michael R ^a   Booth, Valerie ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; SURFACTANT PROTEIN B; 1 PALMITOYL 2 OLEOYLGLYCERO 3 PHOSPHOGLYCEROL; 1-PALMITOYL-2-OLEOYLGLYCERO-3-PHOSPHOGLYCEROL; 1-PALMITOYL-2-OLEOYLPHOSPHATIDYLCHOLINE; 2 OLEOYL 1 PALMITOYLPHOSPHATIDYLCHOLINE; DEUTERIUM; PEPTIDE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL; PHOSPHORUS; SURFACTANT ASSOCIATED PROTEIN;

ARTICLE; CONCENTRATION (PARAMETERS); DEUTERON NUCLEAR MAGNETIC RESONANCE; HUMAN; LIPID BILAYER; MICELLE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROTEIN INTERACTION; SOLID STATE; ANIMAL; CATTLE; CHEMISTRY; NUCLEAR MAGNETIC RESONANCE;

BOVINAE;

ANIMALS; CATTLE; DEUTERIUM; LIPID BILAYERS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDES; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLGLYCEROLS; PHOSPHORUS ISOTOPES; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; PULMONARY SURFACTANT-ASSOCIATED PROTEINS;

EID: 67650354619     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2009.02.027     Document Type: Article

References (66)

1. Clements, J. A. 1957. Surface tension of lung extracts. Proc. Soc. Exp. Biol. Med. 95:170-172.
2. Pattle, R. E. 1955. Properties, function and origin of the alveolar lining layer. Nature. 175:1125-1126.
3. Perez-Gil, J., and K. M. Keough. 1998. Interfacial properties of surfactant proteins. Biochim. Biophys. Acta. 1408:203-217.
4. Been, J. V., and L. J. Zimmermann. 2007. What's new in surfactant? A clinical view on recent developments in neonatology and paediatrics. Eur. J. Pediatr. 166:889-899.
5. Wright, J. R. 2005. Immunoregulatory functions of surfactant proteins. Nat. Rev. Immunol. 5:58-68.
6. Frerking, I., A. Günther, W. Seeger, and U. Pison. 2001. Pulmonary surfactant: functions, abnormalities and therapeutic options. Intens. Care Med. 27:1699-1717.
7. Kingma, P. S., and J. A. Whitsett. 2006. In defense of the lung: surfactant protein A and surfactant protein D. Curr. Opin. Pharmacol. 6: 277-283.
8. Pastva, A. M., J. R. Wright, and K. L. Williams. 2007. Immunomodulatory roles of surfactant proteins A and D: implications in lung disease. Proc. Am. Thorac. Soc. 4:252-257.
9. Serrano, A. G., and J. Pérez-Gil. 2006. Protein-lipid interactions and surface activity in the pulmonary surfactant system. Chem Phys Lipids. 141:105-118.
10. Goerke, J. 1998. Pulmonary surfactant: functions and molecular composition. Biochim. Biophys. Acta. 1408:79-89.
11. Zuo, Y., R. Veldhuizen, A. Neumann, N. Petersen, and F. Possmayer. 2008. Current perspectives in pulmonary surfactant - inhibition, enhancement and evaluation. Biochim. Biophys. Acta. 1778:1947-1977.
12. Revak, S. D., T. A. Merritt, E. Degryse, L. Stefani, M. Courtney, et al. 1988. Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity. J. Clin. Invest. 81: 826-833.
13. Clark, J. C., S. E. Wert, C. J. Bachurski, M. T. Stahlman, B. R. Stripp, et al. 1995. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc. Natl. Acad. Sci. USA. 92:7794-7798.
14. Nogee, L. M., G. Garnier, H. C. Dietz, L. Singer, A. M. Murphy, et al. 1994. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J. Clin. Invest. 93:1860-1863.
15. Beck, D. C., M. Ikegami, C. L. Na, S. Zaltash, J. Johansson, et al. 2000. The role of homodimers in surfactant protein B function in vivo. J. Biol. Chem. 275:3365-3370.
16. Johansson, J., T. Curstedt, and H. Jornvall. 1991. Surfactant protein B: disulfide bridges, structural properties, and kringle similarities. Biochemistry. 30:6917-6921.
17. Andersson, M., T. Curstedt, H. Jornvall, and J. Johansson. 1995. An amphipathic helical motif commonto tumourolytic polypeptide NK-lysin and pulmonary surfactant polypeptide SP-B. FEBS Lett. 362:328-332.
18. Vandenbussche, G., A. Clercx, M. Clercx, T. Curstedt, J. Johansson, et al. 1992. Secondary structure and orientation of the surfactant protein SP-B in a lipid environment. A Fourier transform infrared spectroscopy study. Biochemistry. 31:9169-9176.
19. Kurutz, J. W., and K. Y. C. Lee. 2002. NMR structure of lung surfactant peptide SP-B(11-25). Biochemistry. 41:9627-9636.
20. Booth, V. K., A. J. Waring, F. J. Walther, and K. M. W. Keough. 2004. NMR structures of the C-terminal segment of surfactant protein B in detergent micelles and hexafluoro-2-propanol. Biochemistry. 43: 15187-15194.
21. Sarker, M., A. J. Waring, F. J. Walther, K. M. W. Keough, and V. K. Booth. 2007. Structure of mini-B, a functional fragment of surfactant protein B, in detergent micelles. Biochemistry. 46:11047-11056.
22. Revak, S. D., T. A. Merritt, M. Hallman, G. Heldt, R. J. L. Polla, et al. 1991. The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactants. Pediatr. Res. 29: 460-465.
23. Seurynck-Servoss, S. L., M. T. Dohm, and A. E. Barron. 2006. Effects of including an N-terminal insertion region and arginine-mimetic side chains in helical peptoid analogues of lung surfactant protein B. Biochemistry. 45:11809-11818.
24. Veldhuizen, E. J., A. J. Waring, F. J. Walther, J. J. Batenburg, L. M. van Golde, et al. 2000. Dimeric N-terminal segment of human surfactant protein B (dSP-B(1-25)) has enhanced surface properties compared to monomeric SP-B(1-25). Biophys. J. 79:377-384.
25. Walther, F. J., J. M. Hernandez-Juviel, L. M. Gordon, M. A. Sherman, and A. J. Waring. 2002. Dimeric surfactant protein B peptide sp-b(1-25) in neonatal and acute respiratory distress syndrome. Exp. Lung Res. 28:623-640.
26. Waring, A. J., F. J. Walther, L. M. Gordon, J. M. Hernandez-Juviel, T. Hong, et al. 2005. The role of charged amphipathic helices in the structure and function of surfactant protein B. J. Pept. Res. 66: 364-374.
27. Baatz, J. E., V. Sarin, D. R. Absolom, C. Baxter, and J. A. Whitsett. 1991. Effects of surfactant-associated protein SP-B synthetic analogs on the structure and surface activity of model membrane bilayers. Chem. Phys. Lipids. 60:163-178.
28. Longo, M. L., A. M. Bisagno, J. A. Zasadzinski, R. Bruni, and A. J. Waring. 1993. A function of lung surfactant protein SP-B. Science. 261:453-456.
29. Cochrane, C. G., and S. D. Revak. 1991. Pulmonary surfactant protein B (SP-B): structure-function relationships. Science. 254:566-568.
30. Cochrane, C. G., S. D. Revak, T. A. Merritt, G. P. Heldt, M. Hallman, et al. 1996. The efficacy and safety of KL4-surfactant in preterm infants with respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 153:404-410.
31. Sinha, S. K., T. Lacaze-Masmonteil, A. Valls i Soler, T. E. Wiswell, J. Gadzinowski, et al. 2005. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Pediatrics. 115: 1030-1038.
32. Serrano, A. G., and J. Perez-Gil. 2006. Protein-lipid interactions and surface activity in the pulmonary surfactant system. Chem. Phys. Lipids. 141:105-118.
33. Blanco, O., and J. Perez-Gil. 2007. Biochemical and pharmacological differences between preparations of exogenous natural surfactant used to treat respiratory distress syndrome: role of the different components in an efficient pulmonary surfactant. Eur. J. Pharmacol. 568:1-15.
34. Klenz, U., M. Saleem, M. Meyer, and H. Galla. 2008. Influence of lipid saturation grade and head group charge: a refined lung surfactant adsorption model. Biophys. J. 95:699-709.
35. Cruz, A., L. Vázquez, M. Vélez, and J. Pérez-Gil. 2004. Effect of pulmonary surfactant protein SP-B on the micro- and nanostructure of phospholipid films. Biophys J. 86:308-320.
36. Nag, K., J. G. Munro, K. Inchley, S. Schürch, N. O. Petersen, et al. 1999. SP-B refining of pulmonary surfactant phospholipid films. Am J Physiol. 277:L1179-L1189.
37. Rodriguez-Capote, K., K. Nag, S. Schürch, and F. Possmayer. 2001. Surfactant protein interactions with neutral and acidic phospholipid films. Am J Physiol Lung Cell Mol Physiol. 281:L231-L242.
38. Morley, C. J., A. D. Bangham, N. Miller, and J. A. Davis. 1981. Dry artificial lung surfactant and its effect on very premature babies. Lancet. 1:64-68.
39. Morley, C. J., A. Greenough, N. G. Miller, A. D. Bangham, J. Pool, et al. 1988. Randomized trial of artificial surfactant (ALEC) given at birth to babies from 23 to 34 weeks gestation. Early Hum. Dev. 17:41-54.
40. Lang, C. J., A. D. Postle, S. Orgeig, F. Possmayer, W. Bernhard, et al. 2005. Dipalmitoylphosphatidylcholine is not the major surfactant phospholipid species in all mammals. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289:R1426-R1439.
41. Yu, S., P. G. Harding, N. Smith, and F. Possmayer. 1983. Bovine pulmonary surfactant: chemical composition and physical properties. Lipids. 18:522-529.
42. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
43. Fung, B. M., A. K. Khitrin, and K. Ermolaev. 2000. An improved broadband decoupling sequence for liquid crystals and solids. J. Magn. Reson. 142:97-101.
44. Rainey, J. K., and B. D. Sykes. 2005. Optimizing oriented planar-supported lipid samples for solid-state protein NMR. Biophys. J. 89:2792-2805.
45. Davis, J. H., K. R. Jeffrey, M. Bloom, M. Valic, and T. P. Higgs. 1976. Quadrupolar echo deueron magnetic resonance spectroscopy in ordered hydrocarbon chains. Chem. Phys. Lett. 42:390-394.
46. Sternin, E., B. Fine, M. Bloom, C. P. Tilcock, K. F. Wong, et al. 1988. Acyl chain orientational order in the hexagonal HII phase of phospholipid-water dispersions. Biophys. J. 54:689-694.
47. Burnett, L. J., and B. H. Muller. 1971. Deuteron quadrupole coupling constants in three solid deuterated paraffin hydrocarbons: C2D6, C4D10, C6D14. J. Chem. Phys. 55:5829-5831.
48. Petrache, H. I., S. W. Dodd, and M. F. Brown. 2000. Area per lipid and acyl length distributions in fluid phosphatidylcholines determined by (2)H NMR spectroscopy. Biophys. J. 79:3172-3192.
49. Seelig, J. 1978. 31P nuclear magnetic resonance and the head group structure of phospholipids in membranes. Biochim. Biophys. Acta. 515:105-140.
50. Balla, M. S., J. H. Bowie, and F. Separovic. 2004. Solid-state NMR study of antimicrobial peptides from Australian frogs in phospholipid membranes. Eur. Biophys. J. 33:109-116.
51. Ramamoorthy, A., S. Thennarasu, A. Tan, D. K. Lee, C. Clayberger, et al. 2006. Cell selectivity correlates with membrane-specific interactions: a case study on the antimicrobial peptide G15 derived from granulysin. Biochim. Biophys. Acta. 1758:154-163.
52. Hallock, K. J., D. Lee, and A. Ramamoorthy. 2003. MSI-78, an analogue of the magainin antimicrobial peptides, disrupts lipid bilayer structure via positive curvature strain. Biophys. J. 84:3052-3060.
53. Hyvonen, M. T., T. T. Rantala, and M. Ala-Korpela. 1997. Structure and dynamic properties of diunsaturated 1-palmitoyl-2-linoleoyl-snglycero-3- phosphatidylcholine lipid bilayer from molecular dynamics simulation. Biophys. J. 73:2907-2923.
54. Sachs, J. N., H. Nanda, H. I. Petrache, and T. B. Woolf. 2004. Changes in phosphatidylcholine headgroup tilt and water order induced by monovalent salts: molecular dynamics simulations. Biophys. J. 86:3772-3782.
55. Perez-Gil, J., C. Casals, and D. Marsh. 1995. Interactions of hydrophobic lung surfactant proteins SP-B and SP-C with dipalmitoylphosphatidylcholine and dipalmitoylphosphatidylglycerol bilayers studied by electron spin resonance spectroscopy. Biochemistry. 34:3964-3971.
56. Cruz, A., D. Marsh, and J. Perez-Gil. 1998. Rotational dynamics of spin-labelled surfactant-associated proteins SP-B and SP-C in dipalmitoylphosphatidylcholine and dipalmitoylphosphatidylglycerol bilayers. Biochim. Biophys. Acta. 1415:125-134.
57. Breitenstein, D., J. J. Batenburg, B. Hagenhoff, and H. Galla. 2006. Lipid specificity of surfactant protein B studied by time-of-flight secondary ion mass spectrometry. Biophys. J. 91:1347-1356.
58. Seifert, M., D. Breitenstein, U. Klenz, M. C. Meyer, and H. Galla. 2007. Solubility versus electrostatics: what determines lipid/protein interaction in lung surfactant. Biophys. J. 93:1192-1203.
59. Kang, N., Z. Policova, G. Bankian, M. L. Hair, Y. Y. Zuo, et al. 2008. Interaction between chitosan and bovine lung extract surfactants. Biochim. Biophys. Acta. 1778:291-302.
60. Munford, R. S., P. O. Sheppard, and P. J. O'Hara. 1995. Saposin-like proteins (SAPLIP) carry out diverse functions on a common backbone structure. J. Lipid Res. 36:1653-1663.
61. Ryan, M. A., H. T. Akinbi, A. G. Serrano, J. Perez-Gil, H. Wu, et al. 2006. Antimicrobial activity of native and synthetic surfactant protein B peptides. J. Immunol. 176:416-425.
62. Thennarasu, S., D. K. Lee, A. Tan, U. P. Kari, and A. Ramamoorthy. 2005. Antimicrobial activity and membrane selective interactions of a synthetic lipopeptide MSI-843. Biochim. Biophys. Acta. 1711:49-58.
63. Koenig, B. W., J. A. Ferretti, and K. Gawrisch. 1999. Site-specific deuterium order parameters and membrane-bound behavior of a peptide fragment from the intracellular domain of HIV-1 gp41. Biochemistry. 38:6327-6334.
64. Morrow, M. R., J. Perez-Gil, G. Simatos, C. Boland, J. Stewart, et al. 1993. Pulmonary surfactant-associated protein SP-B has little effect on acyl chains in dipalmitoylphosphatidylcholine dispersions. Biochemistry. 32:4397-4402.
65. Dico, A. S., J. Hancock, M. R. Morrow, J. Stewart, S. Harris, et al. 1997. Pulmonary surfactant protein SP-B interacts similarly with dipalmitoylphosphatidylglycerol and dipalmitoylphosphatidylcholine in phosphatidylcholine/ phosphatidylglycerol mixtures. Biochemistry. 36:4172-4177.
66. Morrow, M. R., J. Stewart, S. Taneva, A. Dico, and K. M. W. Keough. 2004. Perturbation of DPPC bilayers by high concentrations of pulmonary surfactant protein SP-B. Eur. Biophys. J. 33:285-290.